2026-08-16 · fasting, fasting-mimicking-diet, prolon, longo, vlcd

Is the fasting-mimicking diet the same as ProLon?

Not exactly. The fasting-mimicking diet (FMD) is a research protocol developed by Valter Longo at USC — a 5-day, ~750–1,100 kcal/day, plant-based, low-protein, low-carb, moderate-fat pattern designed to mimic the metabolic effects of a water fast while still allowing some food. ProLon is one commercial packaged kit sold by L-Nutra that supplies the food for a 5-day cycle. The kit meets the protocol's macronutrient design and is FDA-cleared as a Class II medical food, but the protocol itself is public and can be approximated with grocery-store ingredients.

How much weight will I lose on a 5-day fasting-mimicking diet?

Expect roughly 1 to 3 kg (about 2 to 7 lb) on the scale immediately after Day 5, with most of that being glycogen and water. Within 5 to 10 days of resuming a normal diet, 60–80% typically returns as glycogen and water restore. Wei 2017 (Sci Transl Med), the primary n=100 RCT on three monthly cycles, reported a mean 2.6 kg loss and about 4 cm of waist reduction measured a week after cycle three — but the follow-up data showed most of the weight loss regressed by six months without a maintenance plan.

Can I do the fasting-mimicking diet without buying ProLon?

Yes, approximately. A DIY 5-day FMD hits similar macros with vegetable soups, olive oil, a small amount of nuts, plant crackers, herbal tea, and water — roughly 1,100 kcal on Day 1 and 725–750 kcal on Days 2–5, keeping protein under about 10% of calories and animal protein at zero. A grocery-store approximation costs around $40 instead of $200–250. Two honest caveats: hitting the exact protein cap that drives the IGF-1 drop is harder without measuring, and the packaged kit is generally reported as less hungry than the DIY version because the food scientists optimized it for satiety at a fixed calorie floor.

How often can I safely do the FMD?

The Wei 2017 RCT used three consecutive monthly cycles as a starter protocol, then transitioned to quarterly (every 3 months) or twice-yearly cycles for maintenance in most participants. Longo's clinical recommendation for generally healthy adults with normal or slightly elevated BMI is a cycle every 3 to 6 months rather than monthly. People with metabolic syndrome or elevated cardiometabolic risk may benefit from a more front-loaded schedule under clinician oversight. There is no evidence base to support monthly cycles indefinitely, and doing so may lead to lean-mass loss and micronutrient shortfall.

Is the fasting-mimicking diet safe for diabetes?

It depends on the type and the medication. In diet- or metformin-controlled type 2 diabetes, a 5-day FMD is generally studied and used with clinician oversight — Sulaj 2022 (JCEM) ran a 6-month periodic-fasting protocol in n=40 adults with T2D and reported modest HbA1c and cardiometabolic improvements. Anyone on insulin, a sulfonylurea, an SGLT2 inhibitor, or a GLP-1 needs dose adjustment before Day 1 and monitored labs — the hypoglycemia, dehydration, and euglycemic DKA risks are real. Type 1 diabetes is a contraindication.

Can I take Ozempic or Wegovy and also do the FMD?

Not without clinician oversight, and generally not a stack we would recommend. GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) already reduce food intake roughly 15–25% and delay gastric emptying, and layering a 5-day very-low-calorie protocol on top increases the risk of dehydration, orthostatic hypotension, and hypoglycemia — especially in the first weeks of a GLP-1 titration when nausea and low intake are already common. If your GLP-1 is producing the effect you need, the FMD adds risk without clear benefit. See our GLP-1 weight-loss overview for the general medication-plus-restriction risk profile.

Does the FMD really extend lifespan?

That claim rests mostly on mouse data, not human evidence. Brandhorst 2015 (Cell Metab) showed lifespan extension and multi-system regeneration in mice on periodic FMD cycles, and Longo has publicly extended that claim to human longevity in interviews and books. In humans, the FMD produces a transient IGF-1 drop that reverts within about a week after refeed, plus modest short-term improvements in inflammatory markers and cardiometabolic risk factors. No randomized controlled trial has shown that the FMD extends human lifespan — the longevity claim is an extrapolation, not proof.

What can I eat during a fasting-mimicking day?

A typical FMD day is plant-based, low-protein, and moderate-fat. On Day 1 (about 1,100 kcal): a vegetable-based soup or two, a small handful of nuts, a plant-based cracker or two, an unsweetened tea or coffee, and plenty of water. On Days 2–5 (about 725–750 kcal): a single vegetable soup or broth-based meal, a small serving of olives or a nut bar, herbal tea, and water. No animal protein, no dairy, no added sugar, and no starchy grains. The macro target is roughly 10% protein, 40% fat (mostly plant-derived), and 50% carbohydrate — a very different profile than a low-carb or keto day.

Fasting-Mimicking Diet (ProLon): 5-Day Protocol, Real Evidence, Honest Verdict

The fasting-mimicking diet is a 5-day, roughly 750–1,100 kcal per day, plant-based protocol developed by Valter Longo at USC and sold commercially as ProLon — a $200 packaged kit that supplies the food for one cycle. It sits between an intermittent fasting schedule and a very-low-calorie diet and is marketed on the promise that a short, quarterly cycle will drive weight loss, improve cardiometabolic markers, and — the more ambitious claim — nudge the body toward “cellular renewal” and longevity. This guide covers what the FMD actually is, what the human evidence supports, what a real 5-day cycle feels like, how it compares to other structured fasting protocols, and where the ProLon commercial premium is buying convenience versus a proprietary mechanism.

What the fasting-mimicking diet is (and what ProLon is)

The fasting-mimicking diet (FMD) is a 5-day protocol designed to trigger a physiological fast state — reduced insulin and IGF-1, mTOR suppression, some ketogenesis by day three or four — while still allowing food. The standard schedule provides about 1,100 kcal on Day 1 and ~750 kcal on Days 2 through 5, with the daily macronutrient split anchored at approximately 10% protein, 40% fat, and 50% carbohydrate. The protein cap is deliberate: the mechanism hypothesis rests on the low-protein signal, not on the calorie floor alone.

ProLon is the commercial productization of that protocol. It is a boxed 5-day kit sold by L-Nutra — the company Longo co-founded — that packages soups, nut bars, plant-based crackers, olives, glycerol-based hydration drinks, and herbal teas designed to hit the macronutrient targets. A single 5-day box retails for roughly $200–250, subscription bundles bring per-box pricing to around $170–200, and the kit is FDA-cleared as a Class II medical food. The protocol itself is public — the food inside the box is the innovation, not a proprietary mechanism.

How the FMD is supposed to work (mechanism)

Four physiological levers are proposed to do the work. The strength of evidence for each varies sharply.

The mechanism story is coherent, but only the first driver — the energy deficit — has an evidence base that would satisfy a skeptical clinician for weight-loss effects specifically. The IGF-1 drop is real and reproducible in humans, but reverts within roughly a week of refeed. The stem-cell renewal claim comes almost entirely from Brandhorst 2015 (Cell Metab) mouse work.

What the human evidence actually shows

The trial base is smaller than the marketing implies. Read together, the studies below show a modest, mostly short-term signal.

The honest read: the primary weight-loss trial is a single n=100 RCT with a clear early signal that fades by month six without a follow-through phase. That is not weak evidence — it is real short-term efficacy — but it is not the transformative long-term protocol the marketing sometimes implies.

What actually happens in a 5-day FMD cycle

The subjective experience matters because it shapes adherence. Most participants describe the same rough arc.

The realistic scale math: expect 1 to 3 kg down immediately after Day 5, and 0.5 to 1 kg of fat loss retained at the two-week mark. Anyone framing the FMD as a mechanism for durable weight loss without maintenance is misreading the primary trial.

FMD vs OMAD vs 5:2 vs alternate-day vs continuous restriction

Structured fasting is a family of protocols, not a single tool. The right fit depends on the goal, the schedule, and the honesty of the expected effect size.

Cheat sheet: FMD is a quarterly 5-day cycle with some food. OMAD is a daily 1-hour eating window. 5:2 is two restricted days per week. Alternate-day fasting alternates. Continuous restriction is the baseline everything else is compared against — and, at matched net intake, most fasting protocols land close to it in weight-loss magnitude per Trepanowski 2017.

ProLon commercial cost analysis

The commercial premium is real, and it is buying convenience and food-scientist macro tuning, not a proprietary mechanism.

The value added by the box is real for some readers — you do not have to plan, cook, or measure — but the mechanism is not proprietary. There is no ingredient in ProLon that a well-designed DIY approximation cannot reproduce for roughly one-sixth of the cost.

Can you DIY the fasting-mimicking diet?

Yes, roughly. A 5-day DIY template that hits the published FMD macro targets:

• Day 1 (~1,100 kcal): two vegetable-based soups (broth, greens, olive oil), one small nut-and-seed bar, a small serving of olives, unsweetened tea, water. Roughly 20 g protein, 45 g fat, 130 g carbohydrate.
• Days 2–5 (~725–750 kcal each): one vegetable soup, one small serving of nuts or olives, one plant-based cracker portion, herbal tea, water. Roughly 15 g protein, 30 g fat, 90 g carbohydrate per day.
• All 5 days: no animal protein, no dairy, no added sugar, no starchy grains, no alcohol. Plenty of water (2–3 L/day). Light electrolytes if physically active.

Groceries for a single cycle run around $40. The honest caveats: hitting the exact ~10% protein cap that drives the IGF-1 drop is harder without weighing food; user reports suggest DIY tends to feel hungrier than the packaged kit because the ProLon food scientists optimized satiety at the fixed calorie floor; and DIY is not an FDA-cleared medical food (ProLon is, as a Class II designation). For a generally healthy adult approximating the protocol as an occasional reset, DIY is a reasonable path. For a clinical use case with defined outcomes, the packaged product exists for a reason.

Who should NOT do the FMD

The candidate list is not universal. The contraindications below are conservative and match how the protocol is applied in clinical settings.

The IGF-1 / longevity claim honestly evaluated

Longo has publicly linked FMD cycles to lifespan extension. That claim rests almost entirely on mouse data. Brandhorst 2015 (Cell Metab) showed lifespan extension and multi-system regeneration in mice on periodic FMD cycles, and Longo 2018 (Cell) reviewed the case for periodic low-protein restriction as a longevity intervention across species.

In humans, the picture is honest but narrower. The FMD reliably produces a transient IGF-1 drop and modest short-term reductions in inflammatory markers and cardiometabolic risk factors. IGF-1 typically returns to baseline within about a week of refeed. No randomized controlled trial has demonstrated that the FMD extends human lifespan — the longevity claim is an extrapolation from animal work, and the marketing framing sometimes obscures that gap. The most honest read is Longo’s own 2018 Cell review posture: mouse data suggests a mechanism worth studying in humans; the human evidence is not yet there.

What FMD is actually useful for (realistic use cases)

Stripping the marketing off, the FMD earns a reasonable place in a short list of use cases.

Not-useful cases: durable weight loss above about 5% of body weight, muscle preservation, endurance-training weeks, active GLP-1 titration, type 1 diabetes, pregnancy, or as a substitute for a maintenance-oriented daily-deficit approach. And it does not replace preserving muscle during weight loss with resistance training and adequate daily protein — a periodic 5-day low-protein cycle is at cross purposes to that goal.

Bottom-line honest verdict

The fasting-mimicking diet produces real short-term weight loss — mostly driven by energy deficit and glycogen depletion — of which most returns within about two weeks in the absence of a maintenance plan. The randomized-trial evidence base is small (one n=100 primary trial plus one 6-month T2D trial), the longevity claim is largely extrapolated from mouse work, and the ProLon commercial premium is convenience and food-scientist macro tuning, not a proprietary mechanism a $40 DIY approximation cannot approach. For durable weight loss, a modest daily deficit combined with adequate protein and resistance training will outperform quarterly FMD cycles; the FMD can fit as an occasional structured reset or as a cardiometabolic-marker tool for a reader who is already at a healthy weight and wants a defined short-term intervention. If you are weighing it against a full clinical intervention like a very-low-calorie diet or the pharmacological path in next-generation weight-loss drugs, the FMD is a much smaller lever.

Sources at a glance